Clinical trial feasibility has traditionally focused on a familiar set of questions: Which countries have the right investigators? Which sites have experience in the...
Clinical trial feasibility has traditionally focused on a familiar set of questions: Which countries have the right investigators? Which sites have experience in the...
Drug development has reached a pivotal point worldwide. Pharmaceutical and biotechnology companies are advancing increasingly complex therapeutic modalities, from monoclonal antibodies and antibody-drug conjugates...
